Lou, 14, with acute and aggressive leukemia, died on 24 September. This summer, his family was mobilized to allow him access to the Revuemenib, a targeted treatment that is not readily available in France.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Lou, 14, with acute and aggressive leukemia, died on 24 September. This summer, his family was mobilized to allow him access to the Revuemenib, a targeted treatment that is not readily available in France.